US 12,233,032 B2
Compositions for management of polycystic ovary syndrome
Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Sarang Bani, Bangalore (IN); and Anjali Pandey, Bangalore (IN)
Assigned to Sami-Sabinsa Group Limited, Bangalore (IN)
Filed by Muhammed Majeed, Bangalore (IN); Kalyanam Nagabhushanam, East Windsor, NJ (US); Sarang Bani, Bangalore (IN); and Anjali Pandey, Bangalore (IN)
Filed on Apr. 29, 2022, as Appl. No. 17/732,655.
Claims priority of provisional application 63/182,166, filed on Apr. 30, 2021.
Prior Publication US 2022/0347120 A1, Nov. 3, 2022
Int. Cl. A61K 31/12 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/42 (2017.01); A61P 5/00 (2006.01); A61P 5/14 (2006.01); A61P 5/24 (2006.01)
CPC A61K 31/12 (2013.01) [A61K 9/0056 (2013.01); A61K 9/1617 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/4866 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61P 5/00 (2018.01); A61P 5/14 (2018.01); A61P 5/24 (2018.01)] 14 Claims
OG exemplary drawing
 
1. A method for the management of polycystic ovary syndrome and its associated conditions in a subject, said method comprising steps of a) identifying a mammalian female subject with polycystic ovary syndrome and b) administering an effective dose of a composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin to the said subject to alleviate polycystic ovary syndrome.